Usefulness of an occlusal device in the treatment of medication overuse headache and persistent idiopathic facial pain

preliminary results

H. A. Didier, M. Curone, V. Tullo, A. H. Didier, R. Cornalba, A. B. Giannì, G. Bussone

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

There is a debate in literature about the therapeutic usefulness of oral devices in patients suffering from Medication Overuse Headache (MOH) or in patients suffering from Persistent Idiopathic Facial Pain (PIFP). From the case histories of 3356 patients, referred to us with a diagnosis of chronic craniofacial pain for assessment of the eventual application of an occlusal device to correct an impaired neuromuscular relationship between the mandible and the maxilla, we selected, following the criteria of the International Classification of Headache Disorders (ICHD-3beta), two groups of patients suffering from MOH and PIFP. All patients of the two groups underwent a Kinesiographic exam and an EMG to evaluate the freeway space (FWS). Patients presenting an impaired FWS were placed in treatment with the application of an occlusal device. At the follow-up after 6 months and after 1 year, we found a significant decrease in pain with regard to the intensity resulting in the reduction of clinical disability. The preliminary data collected using the VAS scale and the MIDAS questionnaire confirm that the neuromuscular cranio-mandibular system can have an important role in the diagnostic process of the MOH and the PIFP, suggesting the usefulness of treatment with an occlusal device, where there is adequate FWS.

Original languageEnglish
Pages (from-to)57-61
Number of pages5
JournalNeurological Sciences
Volume38
DOIs
Publication statusPublished - May 1 2017

Fingerprint

Secondary Headache Disorders
Facial Pain
Equipment and Supplies
Therapeutics
Headache Disorders
Maxilla
Pain Measurement
Mandible
Chronic Pain
Pain

Keywords

  • Freeway space (FWS)
  • Medication overuse headache (MOH)
  • Orthosis
  • Persistent idiopathic facial pain (PIFP)
  • TENS

ASJC Scopus subject areas

  • Dermatology
  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

Usefulness of an occlusal device in the treatment of medication overuse headache and persistent idiopathic facial pain : preliminary results. / Didier, H. A.; Curone, M.; Tullo, V.; Didier, A. H.; Cornalba, R.; Giannì, A. B.; Bussone, G.

In: Neurological Sciences, Vol. 38, 01.05.2017, p. 57-61.

Research output: Contribution to journalArticle

Didier, H. A. ; Curone, M. ; Tullo, V. ; Didier, A. H. ; Cornalba, R. ; Giannì, A. B. ; Bussone, G. / Usefulness of an occlusal device in the treatment of medication overuse headache and persistent idiopathic facial pain : preliminary results. In: Neurological Sciences. 2017 ; Vol. 38. pp. 57-61.
@article{6c0462cf50a0444ea510f25dbe94b8d3,
title = "Usefulness of an occlusal device in the treatment of medication overuse headache and persistent idiopathic facial pain: preliminary results",
abstract = "There is a debate in literature about the therapeutic usefulness of oral devices in patients suffering from Medication Overuse Headache (MOH) or in patients suffering from Persistent Idiopathic Facial Pain (PIFP). From the case histories of 3356 patients, referred to us with a diagnosis of chronic craniofacial pain for assessment of the eventual application of an occlusal device to correct an impaired neuromuscular relationship between the mandible and the maxilla, we selected, following the criteria of the International Classification of Headache Disorders (ICHD-3beta), two groups of patients suffering from MOH and PIFP. All patients of the two groups underwent a Kinesiographic exam and an EMG to evaluate the freeway space (FWS). Patients presenting an impaired FWS were placed in treatment with the application of an occlusal device. At the follow-up after 6 months and after 1 year, we found a significant decrease in pain with regard to the intensity resulting in the reduction of clinical disability. The preliminary data collected using the VAS scale and the MIDAS questionnaire confirm that the neuromuscular cranio-mandibular system can have an important role in the diagnostic process of the MOH and the PIFP, suggesting the usefulness of treatment with an occlusal device, where there is adequate FWS.",
keywords = "Freeway space (FWS), Medication overuse headache (MOH), Orthosis, Persistent idiopathic facial pain (PIFP), TENS",
author = "Didier, {H. A.} and M. Curone and V. Tullo and Didier, {A. H.} and R. Cornalba and Giann{\`i}, {A. B.} and G. Bussone",
year = "2017",
month = "5",
day = "1",
doi = "10.1007/s10072-017-2863-3",
language = "English",
volume = "38",
pages = "57--61",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",

}

TY - JOUR

T1 - Usefulness of an occlusal device in the treatment of medication overuse headache and persistent idiopathic facial pain

T2 - preliminary results

AU - Didier, H. A.

AU - Curone, M.

AU - Tullo, V.

AU - Didier, A. H.

AU - Cornalba, R.

AU - Giannì, A. B.

AU - Bussone, G.

PY - 2017/5/1

Y1 - 2017/5/1

N2 - There is a debate in literature about the therapeutic usefulness of oral devices in patients suffering from Medication Overuse Headache (MOH) or in patients suffering from Persistent Idiopathic Facial Pain (PIFP). From the case histories of 3356 patients, referred to us with a diagnosis of chronic craniofacial pain for assessment of the eventual application of an occlusal device to correct an impaired neuromuscular relationship between the mandible and the maxilla, we selected, following the criteria of the International Classification of Headache Disorders (ICHD-3beta), two groups of patients suffering from MOH and PIFP. All patients of the two groups underwent a Kinesiographic exam and an EMG to evaluate the freeway space (FWS). Patients presenting an impaired FWS were placed in treatment with the application of an occlusal device. At the follow-up after 6 months and after 1 year, we found a significant decrease in pain with regard to the intensity resulting in the reduction of clinical disability. The preliminary data collected using the VAS scale and the MIDAS questionnaire confirm that the neuromuscular cranio-mandibular system can have an important role in the diagnostic process of the MOH and the PIFP, suggesting the usefulness of treatment with an occlusal device, where there is adequate FWS.

AB - There is a debate in literature about the therapeutic usefulness of oral devices in patients suffering from Medication Overuse Headache (MOH) or in patients suffering from Persistent Idiopathic Facial Pain (PIFP). From the case histories of 3356 patients, referred to us with a diagnosis of chronic craniofacial pain for assessment of the eventual application of an occlusal device to correct an impaired neuromuscular relationship between the mandible and the maxilla, we selected, following the criteria of the International Classification of Headache Disorders (ICHD-3beta), two groups of patients suffering from MOH and PIFP. All patients of the two groups underwent a Kinesiographic exam and an EMG to evaluate the freeway space (FWS). Patients presenting an impaired FWS were placed in treatment with the application of an occlusal device. At the follow-up after 6 months and after 1 year, we found a significant decrease in pain with regard to the intensity resulting in the reduction of clinical disability. The preliminary data collected using the VAS scale and the MIDAS questionnaire confirm that the neuromuscular cranio-mandibular system can have an important role in the diagnostic process of the MOH and the PIFP, suggesting the usefulness of treatment with an occlusal device, where there is adequate FWS.

KW - Freeway space (FWS)

KW - Medication overuse headache (MOH)

KW - Orthosis

KW - Persistent idiopathic facial pain (PIFP)

KW - TENS

UR - http://www.scopus.com/inward/record.url?scp=85019540321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019540321&partnerID=8YFLogxK

U2 - 10.1007/s10072-017-2863-3

DO - 10.1007/s10072-017-2863-3

M3 - Article

VL - 38

SP - 57

EP - 61

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

ER -